• Shopping cart is empty.

    The International Society for Aerosols in Medicine


    Who we are & What we do

    Our Objectives

    The International Society for Aerosols in Medicine (ISAM) was founded in 1970. The objectives of ISAM are to stimulate and further the interdisciplinary cooperation and exchange of information in all aspects of aerosol research in medicine including health effects of inhaled aerosols and pulmonary drug delivery. ISAM sponsors international conferences, publications, study groups and special research projects. To introduce new therapies into practice ISAM has organized educational seminars, and provided advice on basic and advanced levels to staff and international organizations such as the World Health Organization (WHO), the European Respiratory Society and the American Thoracic Society (ATS). ISAM is a non-profit organization.

    ISAM Board

    Current ISAM Board Members are: Chantal Darquenne, President (USA); Rajiv Dhand, Past-President (USA); Barbara Rothen, President-Elect (Switzerland); Andrew Martin, General Secretary (Canada); Sabine Haeussermann, Treasurer (Germany). They are assisted by an international group of 5 additional Board Members: Philip Kuehl (USA), Jim Fink (USA), Stephan Ehrmann (France), Bernhard Müllinger (Germany) and Jessica Oakes (USA). The Ex Officio member of the Board is Gerald C. Smaldone, JAMPDD Editor (USA). Tim Corcoran is the JAMPDD Associate Editor (USA).

    Our Events

    ISAM sponsors an International Congress every two years. The most recent was held in Montreux (Switzerland) in May 2019. The next Congress will be held in Boise, Idaho (USA) in May 2021. Check this website for further information. In intervening years, Regional Congresses and Focus Symposia on specific topics are organized and we present Webinar series to foster education and share recent scientific data with our members. If you have a special interest in aerosols, you should consider becoming a member of ISAM.  

    Who we are

    Currently, there are about 250 members. They represent different disciplines connected to aerosols in the lung, e.g. physicians, physicists, biologists, pharmacologists, respiratory care practitioners, engineers and others. Please join us and receive all benefits of membership in ISAM. The society also leverages network groups to foster communication within focus areas and to ensure that the congresses present current and novel information for the membership. The networking groups are focused in the following areas: Regulatory Affairs and Standardization Issues; New Devices and Emerging Therapies; Pediatrics and Cystic Fibrosis; Imaging, Modeling and Physiology of Aerosols in the Lung; Environmental/Occupational Health; Young investigators/early career members; and Women in Aerosol Research. Finally, ISAM fosters and encourages promising new researchers, and recognizes eminent, long-standing career achievements within these areas of interest through a generous awards program.

    Our Journal

    The Journal of Aerosol Medicine and Pulmonary Drug Delivery, also known as JAMPDD, is the official Journal of ISAM. Published bimonthly by Mary Ann Liebert Inc., JAMPDD serves as a forum for studies involving inhalation of particles and gases in the respiratory tract, including the use of aerosols as tools to study basic structural and functional phenomena, their use as selective delivery systems for medication and the toxic effects of inhaled agents. Gerald C. Smaldone, MD PhD (Stony Brook, NY) is the Editor, assisted by Tim Corcoran, PhD, Associate editor (University of Pittsburgh, USA) and an international Editorial Board of 37 members. The Journal is indexed by the major electronic indices and available electronically and in hardcopy to members of ISAM.

    Please review our policy about the Involvement of ISAM Members and Others Participating in ISAM Activities with the Tobacco Industry.